4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-251817
Chief Medical Officer sold 3,786 shares at $55.62 ($210,577)
- Chief Medical Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Naimish Chief Medical Officer | 2026-05-28 | Option exercise | +10,000 | 23,143 | D: show line 1 in the form | ||
| Patel Naimish Chief Medical Officer | 2026-05-29 | Sale | −3,786 | $55.62 | $210,577 | 19,357 | D: show line 2 in the form |
| Open-market sales · 3,786 sh · avg $55.62 · $210,577 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Naimish Chief Medical Officer | 2026-05-28 | Option exercise · Restricted Stock Units | −10,000 | 20,000 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…